Picture of Kuangli Bio Tech Holdings Co logo

6431 Kuangli Bio Tech Holdings Co Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapSucker Stock

Annual cashflow statement for Kuangli Bio Tech Holdings Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line49.5-84.8-124-182-193
Depreciation
Amortisation
Non-Cash Items-71.412.81645.322.9
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital3.612.02-15.3-12-62.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities21.7-9.24-62.4-65.2-145
Capital Expenditures-40.6-34.2-25.2-17.4-9.32
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-52.931.1-5.2979.723.4
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-93.4-3.16-30.562.314.1
Financing Cash Flow Items6.38-35303
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities121-11.117.5-16.1314
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash47.7-20.3-78.7-21.6167